New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat.
Publication
, Journal Article
Sawinski, D; Forde, KA; Wyatt, CM
Published in: Am J Kidney Dis
July 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am J Kidney Dis
DOI
EISSN
1523-6838
Publication Date
July 2018
Volume
72
Issue
1
Start / End Page
7 / 9
Location
United States
Related Subject Headings
- Urology & Nephrology
- Sulfonamides
- Quinoxalines
- Pyrrolidines
- Proline
- Leucine
- Lactams, Macrocyclic
- Kidney Failure, Chronic
- Humans
- Hepatitis C
Citation
APA
Chicago
ICMJE
MLA
NLM
Sawinski, D., Forde, K. A., & Wyatt, C. M. (2018). New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat. Am J Kidney Dis, 72(1), 7–9. https://doi.org/10.1053/j.ajkd.2018.01.049
Sawinski, Deirdre, Kimberly A. Forde, and Christina M. Wyatt. “New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat.” Am J Kidney Dis 72, no. 1 (July 2018): 7–9. https://doi.org/10.1053/j.ajkd.2018.01.049.
Sawinski D, Forde KA, Wyatt CM. New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat. Am J Kidney Dis. 2018 Jul;72(1):7–9.
Sawinski, Deirdre, et al. “New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat.” Am J Kidney Dis, vol. 72, no. 1, July 2018, pp. 7–9. Pubmed, doi:10.1053/j.ajkd.2018.01.049.
Sawinski D, Forde KA, Wyatt CM. New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat. Am J Kidney Dis. 2018 Jul;72(1):7–9.
Published In
Am J Kidney Dis
DOI
EISSN
1523-6838
Publication Date
July 2018
Volume
72
Issue
1
Start / End Page
7 / 9
Location
United States
Related Subject Headings
- Urology & Nephrology
- Sulfonamides
- Quinoxalines
- Pyrrolidines
- Proline
- Leucine
- Lactams, Macrocyclic
- Kidney Failure, Chronic
- Humans
- Hepatitis C